REMSleep Holdings, Inc. Announces Distributor Request for DELTAWAVE Nasal Pillows System Samples
REMSleep Holdings, Inc. (OTCQB: RMSL) has announced that a major CPAP industry distributor has requested samples of its new DELTAWAVE Nasal Pillows System. This development marks a significant milestone for REMSleep in its mission to revolutionize sleep apnea treatment. The company is currently preparing samples for shipment, highlighting the product's design for enhanced user comfort and effectiveness.
CEO Tom Wood expressed enthusiasm about the potential impact, viewing it as an opportunity to showcase their innovative product to a leading distributor. REMSleep anticipates that this could lead to broader distribution opportunities. The company remains committed to keeping shareholders informed about progress in advancing sleep apnea treatment solutions.
REMSleep Holdings, Inc. (OTCQB: RMSL) ha annunciato che un importante distributore dell'industria del CPAP ha richiesto campioni del suo nuovo Sistema Nasale a Cuscinetti DELTAWAVE. Questo sviluppo segna un importante traguardo per REMSleep nella sua missione di rivoluzionare il trattamento dell'apnea notturna. L'azienda sta attualmente preparando campioni per la spedizione, evidenziando il design del prodotto per un comfort e un'efficacia migliorati per gli utenti.
Il CEO Tom Wood ha espresso entusiasmo per il potenziale impatto, vedendolo come un'opportunità per mostrare il loro prodotto innovativo a un distributore di primo piano. REMSleep prevede che questo potrebbe portare a opportunità di distribuzione più ampie. L'azienda rimane impegnata a mantenere informati gli azionisti sui progressi nell'avanzamento delle soluzioni per il trattamento dell'apnea notturna.
REMSleep Holdings, Inc. (OTCQB: RMSL) ha anunciado que un importante distribuidor de la industria CPAP ha solicitado muestras de su nuevo Sistema de Almohadas Nasales DELTAWAVE. Este desarrollo marca un hito significativo para REMSleep en su misión de revolucionar el tratamiento de la apnea del sueño. La compañía está preparando muestras para el envío, destacando el diseño del producto para mejorar la comodidad y la efectividad del usuario.
El CEO Tom Wood expresó entusiasmo por el impacto potencial, considerándolo una oportunidad para mostrar su producto innovador a un distribuidor líder. REMSleep anticipa que esto podría llevar a oportunidades de distribución más amplias. La empresa sigue comprometida a mantener a los accionistas informados sobre los avances en las soluciones para el tratamiento de la apnea del sueño.
REMSleep Holdings, Inc. (OTCQB: RMSL)는 주요 CPAP 산업 유통업체가 새로운 DELTAWAVE 코 패드 시스템의 샘플을 요청했다고 발표했습니다. 이 발전은 REMSleep이 수면 무호흡증 치료를 혁신하는 사명에 있어 중요한 이정표가 됩니다. 이 회사는 현재 사용자 편안함과 효율성을 높이기 위해 설계된 제품의 샘플을 배송 준비 중입니다.
CEO Tom Wood는 이것이 주요 유통업체에 혁신적인 제품을 선보일 기회로 보여져 잠재적인 영향에 대한 열정을 표명했습니다. REMSleep은 이것이 더 넓은 유통 기회로 이어질 수 있을 것으로 기대하고 있습니다. 이 회사는 수면 무호흡증 치료 솔루션을 발전시키는 진행 상황에 대해 주주들에게 정보를 지속적으로 제공할 것을 약속합니다.
REMSleep Holdings, Inc. (OTCQB: RMSL) a annoncé qu'un important distributeur de l'industrie CPAP a demandé des échantillons de son nouveau Système de Coussins Nasaux DELTAWAVE. Ce développement marque une étape significative pour REMSleep dans sa mission de révolutionner le traitement de l'apnée du sommeil. L'entreprise prépare actuellement des échantillons pour expédition, mettant en avant la conception du produit qui améliore le confort et l'efficacité pour l'utilisateur.
Le PDG Tom Wood a exprimé son enthousiasme concernant l'impact potentiel, le considérant comme une opportunité de présenter leur produit innovant à un distributeur de premier plan. REMSleep anticipe que cela pourrait mener à des opportunités de distribution plus larges. L'entreprise s'engage à tenir les actionnaires informés des progrès dans l'avancement des solutions de traitement de l'apnée du sommeil.
REMSleep Holdings, Inc. (OTCQB: RMSL) hat bekannt gegeben, dass ein wichtiger CPAP-Industrieverteiler Proben seines neuen DELTAWAVE Nasenpolstersystems angefordert hat. Diese Entwicklung stellt einen wichtigen Meilenstein für REMSleep in seiner Mission dar, die Behandlung von Schlafapnoe zu revolutionieren. Das Unternehmen bereitet derzeit Proben für den Versand vor und hebt das Produktdesign hervor, das auf erhöhten Komfort und Wirksamkeit für den Benutzer ausgelegt ist.
CEO Tom Wood äußerte Begeisterung über die mögliche Auswirkung und sieht darin eine Gelegenheit, ihr innovatives Produkt einem führenden Verteiler vorzustellen. REMSleep erwartet, dass dies zu umfangreicheren Vertriebsmöglichkeiten führen könnte. Das Unternehmen bleibt verpflichtet, die Aktionäre über den Fortschritt bei der Weiterentwicklung von Schlafapnoe-Behandlungslösungen auf dem Laufenden zu halten.
- Major CPAP industry distributor requested samples of DELTAWAVE Nasal Pillows System
- Potential for broader distribution opportunities
- Growing interest in REMSleep's innovative products
- None.
CLEARWATER, Fla., July 24, 2024 (GLOBE NEWSWIRE) -- REMSleep Holdings, Inc. (OTCQB: RMSL), a leader in innovative sleep apnea products, is thrilled to announce that a significant distributor in the CPAP industry has requested samples of its new nasal interface, the DELTAWAVE Nasal Pillows System. This request marks a pivotal step in REMSleep's mission to revolutionize sleep apnea treatment with cutting-edge technology and superior comfort.
REMSleep is currently in the process of preparing the DELTAWAVE Nasal Pillows System samples for shipment. This state-of-the-art product is designed to enhance user experience by providing a more comfortable and effective solution for CPAP users.
Tom Wood, CEO of REMSleep, expressed his excitement about the potential impact of this development:
"We are incredibly excited about the opportunity to showcase our DELTAWAVE Nasal Pillows System to a leading distributor in the CPAP industry. This request signifies a major milestone for REMSleep and reflects the growing interest in our innovative products. We are confident that once they experience the superior comfort and effectiveness of DELTAWAVE, it will lead to further opportunities and broader distribution. We remain committed to keeping our shareholders informed and updated on our progress as we continue to drive innovation in the sleep apnea market."
REMSleep will keep its shareholders updated on any significant progress or developments resulting from this engagement. The company remains dedicated to advancing sleep apnea treatment and improving the quality of life for millions of individuals suffering from sleep apnea worldwide.
About REMSleep Holdings, Inc.
REMSleep Holdings, Inc. is a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive sleep apnea patients. Our focus is primarily designing and manufacturing devices and products for the treatment of sleep apnea and other respiratory conditions. With over 30 years of collective experience in CPAP therapy, the REMSleep team has extensive knowledge and understanding of CPAP and the challenges of patient compliance. We diligently strive for our products to make a difference and improve the condition of those suffering from sleep apnea.
Forward-looking Statements
This press release may contain forward-looking statements regarding the Company. All statements, other than statements of historical fact included herein, are "forward-looking statements" including statements regarding the Company's future prospects and risks in investing in Company's common stock. These statements are based upon the Company's current expectations and speak only as of the date hereof. Financial performance in one period does not necessarily mean continued or better performance in the future. The Company's actual results in any endeavor may differ materially and adversely from those expressed in any forward-looking statements as a result of various factors and uncertainties, which factors or uncertainties may be beyond our ability to foresee or control. Other risk factors include the status of the Company's common stock as a "penny stock" and those risk factors stated in reports filed with the U.S. Securities and Exchange Commission or SEC on its EDGAR website (www.sec.gov)
Contact:
REMSleep Holdings, Inc.
14175 ICOT Blvd
Suite 300
Clearwater, FL 33760
Email: twood@remsleep.com
IR Contact:
Preya Narain
FAQ
What is the DELTAWAVE Nasal Pillows System by REMSleep Holdings (RMSL)?
Has REMSleep Holdings (RMSL) received any distributor interest for its DELTAWAVE product?
What potential impact could the distributor's sample request have on REMSleep Holdings (RMSL)?
When did REMSleep Holdings (RMSL) announce the distributor's request for DELTAWAVE samples?
